AILERON THERAPEUTICS
Aileron Therapeutics is a biopharmaceutical company that develops a class of drugs called Stapled Peptides. Stapled Peptides represent the first general solution for modulating intracellular protein-protein interactions that are critical control points to nearly all functions of a cell.
AILERON THERAPEUTICS
Social Links:
Industry:
Biopharma Biotechnology Therapeutics
Founded:
2005-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.aileronrx.com
Total Employee:
11+
Status:
Active
Contact:
+1 617 995 0900
Email Addresses:
[email protected]
Total Funding:
256.21 M USD
Technology used in webpage:
HSTS Amazon JQuery CDN Mobile Optimized Amazon Frankfurt Region Pexels Unsplash Drupal Adobe Dynamic Tag Management Drupal 10
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
CAMP4 Therapeutics
CAMP4 Therapeutics is a biotechnology company that uses RNA to restore healthy gene expression.
Cytokinetics
Cytokinetics is a biopharmaceutical company developing therapies for debilitating diseases.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2023-11-01 | Lung Therapeutics | Lung Therapeutics acquired by Aileron Therapeutics | N/A |
Investors List
Nantahala Capital Management
Nantahala Capital Management investment in Post-IPO Equity - Aileron Therapeutics
Bios Partners
Bios Partners investment in Post-IPO Equity - Aileron Therapeutics
Lincoln Park Capital Fund
Lincoln Park Capital Fund investment in Post-IPO Secondary - Aileron Therapeutics
Acorn Bioventures
Acorn Bioventures investment in Post-IPO Secondary - Aileron Therapeutics
Grand Oaks Capital
Grand Oaks Capital investment in Post-IPO Secondary - Aileron Therapeutics
Satter Investment Management
Satter Investment Management investment in Post-IPO Secondary - Aileron Therapeutics
Maven Investment Partners US
Maven Investment Partners US investment in Post-IPO Secondary - Aileron Therapeutics
Biotechnology Value Fund
Biotechnology Value Fund investment in Post-IPO Secondary - Aileron Therapeutics
Novartis Venture Fund
Novartis Venture Fund investment in Series E - Aileron Therapeutics
Excel Venture Management
Excel Venture Management investment in Series E - Aileron Therapeutics
Key Employee Changes
Official Site Inspections
http://www.aileronrx.com Semrush global rank: 4.63 M Semrush visits lastest month: 2.07 K
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 15.197.225.128
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Aileron Therapeutics"
Aileron Therapeutics - Crunchbase Company Profile
Contact Email [email protected] Phone Number +1 617 995 0900 Aileron Therapeutics is a biopharmaceutical company that develops a class of drugs …See details»
Org Chart Aileron Therapeutics - The Official Board
Www.aileronrx.com. has 19 executives and 1 subsidiary +1 617 995 0900; Add an executive. Aileron Therapeutics (ALRN) News . Anything missing? We search for you. Print or download . CEO & Director. Brian Windsor. CEO & Director @ …See details»
Aileron Therapeutics, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Aileron Therapeutics, Inc. of Boston, MA. Get the latest business insights from Dun & Bradstreet.See details»
Aileron Therapeutics Information - RocketReach
Following the acquisition of Lung Therapeutics in October 2023, Aileron is shifting its disease focus to advancing a pipeline of first-in-class medicines to address significant unmet medical …See details»
Aileron Therapeutics - Overview, News & Similar companies
Oct 30, 2023 Aileron Therapeutics contact info: Phone number: (617) 995-0900 Website: www.aileronrx.com What does Aileron Therapeutics do? Aileron is a chemoprotection …See details»
Aileron Therapeutics - Craft
Oct 29, 2024 Aileron Therapeutics has 4 employees across 2 locations. See insights on Aileron Therapeutics including office locations, competitors, revenue, financials, executives, …See details»
Whois aileronrx.com
Jan 5, 2007 Domain Services Transfer your Domain Consolidate your domains quickly & easily Free With Every Domain Free services included with every domainSee details»
Aileron Therapeutics
Feb 25, 2025 Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States. The company is developing ALRN-6924, which is in Phase 1 …See details»
Aileron Therapeutics - VentureRadar
"Aileron Therapeutics is a clinical stage biopharmaceutical company that is developing first-in-class therapeutics based on its proprietary Stapled Peptide drug platform.See details»
Aileron Therapeutics Company Profile | Management and
[email protected]: Aileron Therapeutics Top Competitors. Company Employees Revenue Top technologies; Protalex Inc. n/a: $1.6 M: Angiochem Inc. n/a: $5.6 M: Bicycle Therapeutics …See details»
Aileron Therapeutics - Company Profile & Staff Directory
Aileron is a clinical stage chemoprotection oncology company focused on developing medicines to make chemotherapy safer and thereby more effective to save more patients’ lives. ALRN …See details»
Rein Therapeutics Inc Company Profile - Overview - GlobalData
Website aileronrx.com Telephone 1 737 8021989. No of Employees 15. Industry Pharmaceuticals and Healthcare. Ticker Symbol & Exchange ALRN (NASD) EPS XYZ. Net Income (2023) XYZ …See details»
Aileron Therapeutics Company Overview, Contact Details
Wanstall leaves Aileronrx as Chief Financial Officer and Treasurer. Mr. Wanstall, age 53, joins the Company from Aileron Therapeutics, Inc., a clinical stage chemoprotection oncology company, …See details»
Aileron Therapeutics - Overview, News & Similar companies
May 15, 2024 Who is Aileron Therapeutics. Aileron is a chemoprotection oncology company that aspires to develop medicines to make chemotherapy safer and thereby more effective to save …See details»
Aileron Therapeutics - Scientist.com
Aileronrx.com: Headquarters: Cambridge, MA, US Company Type: Small Business (1-10M TTM Revenue) Description Sites ... If your organization has a Scientist.com marketplace, you can …See details»
Aileron Therapeutics Announces Acquisition of Lung Therapeutics
Oct 31, 2023 Management and Organization. ... For more information on the acquisition, please visit the investor section of Aileron's website at investors.aileronrx.com. About Aileron …See details»
Aileron Therapeutics Appoints Veterans of Life Sciences Industry …
May 11, 2011 CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Aileron Therapeutics, Inc., a biopharmaceutical company that has defined a new class of drugs called Stapled Peptides, …See details»
Aileron Therapeutics Announces CEO Transition
Current President and Chief Operating Officer, Brian Windsor, Ph.D., appointed Chief Executive Officer Dr. Windsor to lead Aileron into a new era focused on advancing a pipeline of first-in …See details»
Working At Aileron: Company Overview and Culture - Zippia
Mar 14, 2024 Aileron's DOC System is a proven approach to running a thriving business that has empowered thousands of leaders to transform their businesses Founded in 1996, Aileron …See details»
Aileron Therapeutics Announces Completion of $35.9 Million …
Jan 11, 2021 \-- Several existing Aileron investors, including Satter Medical Technology Partners and Lincoln Park Capital Fund, LLC, also participated in the offering \--– Aileron plans to use …See details»